Figure 4
Protocols for patients allocated to EPL or PBO groups in the intervention study. Patients with CKD were randomly allocated to be treated with EPL (n = 22) or with PBO as the control group (n = 26).
Figure 4 | Scientific Reports
Protocols for patients allocated to EPL or PBO groups in the intervention study. Patients with CKD were randomly allocated to be treated with EPL (n = 22) or with PBO as the control group (n = 26).
